Abstract. In order to evaluate the basis for changes in plasma concentrations ofthe third component of complement (C3) during inflammation, we injected purified radiolabeled C3 into normal New Zealand White rabbits and into rabbits with turpentine-induced pleurisy. In the normal animals, C3 was distributed between the intravascular compartment (75%) and the extravascular space (25%), with an exchange rate of 1.8±0.1% of the plasma pool per hour. The fractional catabolic rate (FCR) was 2.7±0.3% of the C3 plasma pool per hour, the synthesis rate was 1.0±0.2 mg C3/kg per h, and the plasma concentration was 1.23±0.3 mg C3/ml. Rabbits with turpentine-induced inflammation showed a shift of the volume ofC3 distribution in favor ofthe extravascular compartment. In addition, the rate by which '25I-C3 was cleared from the circulation increased by 29% and was related to the appearance of 20% of the C3-bound circulating radioactivity in the affected pleural cavity at the zenith of inflammation. The FCR, calculated by measuring urinary excretion of radiolabel, increased by only 9% and was probably related to the C3 degradation that was observed in the pleural fluid during the early stages of inflammation. The plasma C3 concentration reached a peak at 230% of the baseline concentration, owing to an increase in the rate of synthesis by as much as 480%. The latter increase could be blocked by cycloheximide, an inhibitor of protein synthesis. We conclude that the increase of plasma C3 in the acute phase is due to stimulated synthesis, which is partially offset by a rise in FCR and by a shift of protein to the site of inflammation.
Introduction
Acute phase proteins (APPs)l are a group of plasma proteins, the concentrations of which change in response to acute inflammation. The measurement of levels of APP can be helpful in diagnosing and monitoring inflammation, as well as tissue destruction, e.g., myocardial infarction. The third component of complement (C3) is such an APP, since several investigators observed elevations in the plasma C3 concentration after various inflammatory stimuli in different species. Almost uniformly, a two-fold increase was reported during Schistosoma mansoni infection in mice (1) after intramuscular injection ofturpentine into mice (2) , and recently in our laboratory after turpentine pleurisy was induced in rabbits. (Giclas, P. C., U. Manthei, B. Thron-Weber, and R. C. Strunk. Manuscript submitted for publication.) Not yet described are the relationships between synthesis rates, the rates of distribution, and the catabolism that lead to the observed plasma C3 level alterations during acute inflammation. Other APPs have been looked at in this respect; after intramuscular injection of turpentine the synthesis rate of rabbit C-reactive protein (CRP) increased 85-fold and the fractional catabolic rate (FCR) remained unchanged (3). Atencio et al. (4) injected rabbits with ACTH and found a three-to ninefold increase in the synthesis rate offibrinogen but no change in the FCR; the result was a twofold rise in the plasma fibrinogen concentration. Another component ofthe complement pathway, C9, was identified as an APP in guinea pigs by Takahashi et al. (5) who showed a twofold increase in the plasma level as a result of a fivefold stimulation of the synthesis rate after intramuscular turpentine injection. A possible alteration of the FCR was not examined by these authors.
It is the balance between synthesis, distribution, and catabolism that determines the plasma concentration of any protein at a given time. C3 is a key protein of the complement pathway and may serve a specific purpose in the inflammatory process. Comparing normal synthesis and metabolic parameters with 1 . Abbreviations used in this paper: APP, acute phase protein; C, component of complement; CRP, C-reactive protein; FCR, fractional catabolic rate; NZW, New Zealand White; PCR, plasma clearance rate; those rates observed under pathologic conditions may, therefore, give insight into the biological role of this protein and might allow adjustment of therapeutic interventions.
The purpose of this study was to determine, in the rabbit, to what extent locally induced inflammation such as turpentine pleurisy alters the synthesis rate ofC3, the rates of its distribution between various body compartments, and its catabolism. Antibodies to rabbit C3 and other rabbit plasma proteins were either raised by immunizing goats against the purified component as described in reference 6, or purchased from Nordic Immunological Laboratories (El Toro, CA). The commercial preparations were directed against the rabbit protein with the exception of anti-CRP and anti-ceruloplasmin (ATAB, Scarborough, ME), which were directed against the human equivalent but known to cross-react with the rabbit species. Rabbit C3 hemolytic activity was measured in plasma samples according to Giclas et al. (6) , and C3 antigen was measured with goat anti-rabbit C3, either by radial immunodiffusion (7) or rocket immunoelectrophoresis (8) .
TCA precipitation. All precipitations of radiolabelled, purified C3 in both plasma and urine were carried out at a final concentration of 10% TCA in the presence of 20% normal rabbit serum as carrier protein.
C3 preparation. Rabbit C3 was purified by the method of Giclas et al. (6) which includes the addition of inhibitors of C3-cleaving enzymes throughout the entire process. Immunodiffusion against antibodies to rabbit immunoglobulins, C3, C5, C6, factor H, CRP, ceruloplasmin, and albumin showed that the final product reacted only with anti-C3. It migrated as one band with an apparent molecular weight (Mr) of 180,000 in SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Two subunits with Mr of 70,000 and 120,000, respectively, were observed on SDS-PAGE after reduction with 5% 2-mercaptoethanol. The purified preparation showed a single arc by crossed immunoelectrophoresis into agar containing goat anti-whole rabbit serum. The specific hemolytic activity was 1.2 X 10'0 effective molecules/mg protein, comparable to the specific activity of C3 in the purification procedure described by Giclas et al. (6) .
Radioiodination. 125I or '"'I was covalently linked to C3 or rabbit serum albumin (RSA) by a modification of the lodo-Gen method (9) .
Glass vials, precoated with 20 Mg of lodo-Gen reagent also containing 0.5 g of Iodo-Gen-coated glass beads, were thoroughly washed with 0.2 M potassium phosphate buffer, pH 7.3. 100 ul of the buffer remained in the vial when 100 ul phosphate buffered saline (pH 7.3) containing 100 MAg purified C3 was added. 0.5-1.0 mCi of '25I or '3'I was added and allowed to react for 30 min at 4°C with repeated gentle mixing. The mixture then was passed through glass wool and Sephadex G75 to remove the glass beads and was collected in a tube containing 100 Ml (1) i.e., the fraction of the plasma pool catabolized per hour. This method is based on analysis of the disappearance of radioactivity from the circulation only. Ruddy et al. (10) reviewed data from turnover studies of radiolabeled complement protein in normal volunteers to establish the parameters during steady state. They recognized a rapidly cleared fraction ofthe iodinated C3 and were able to show a positive correlation between the size of this fraction and the loss of specific hemolytic activity of the individual preparation before injection. This inactivation was present even though polyacrylamide gel disc electrophoresis, immunoelectrophoresis, or immunoprecipitation had failed to demonstrate contaminants or alterations in the C3 preparations. In findings similar to those of Ruddy et al. (10), we have observed a rapidly cleared fraction in all our animals. For example, in one study a 35% loss of specific hemolytic activity measured after the iodination procedure was associated with rapid clearance of 16% of the total injected radioactivity. Biological screening of '25I-C3 in donor rabbits for 24 h before injection into the recipient animals was done in two experiments, by methods similar to those of Charlesworth et al. ( 17) (rabbits 5 and 6, Table I ). The results in the two recipient rabbits demonstrated that the biological screening failed to remove the fast compartment (16.4±4.6%, n = 2 vs. 24.2±6.9%, n = 6). Ruddy and co-workers recommended that the clearance curves be normalized to two exponents by subtracting the rapidly cleared fraction from the total injected and by replotting the difference. In accordance with this recommendation, all curve analysis data presented in this paper have been calculated after correction of the '25I-C3 clearance curves to two exponents.
When the urinary "25I activity (U) for a given time (t) period (in hours) is expressed as fraction of the mean plasma activity (X) for the same time period, it represents the FCR for this period. The following equation was used to determine the urine-plasma derived FCR:
i.e., the fraction of the plasma pool catabolized per hour. Fig. 1 shows the model described by Atencio and Reeve (14, 16) that we used in a modified version for our calculations. The coefficients for the exchange rates between the compartments (j, and j2, see 
and i2 = C,b2 + C2b, .
The extravascular volume of C3 distribution (Y) was determined as a fraction of the intravascular space from the equation (14): As will be shown later, a change in the FCR and the total body distribution factor occurred during turpentine pleurisy. Since the clearance rate of the iodinated C3 from the circulation represents the sum of catabolism and unidirectional accumulation in the newly created compartment, the pleural cavity, the term FCR is no longer applicable, and the rate of clearance from the circulation was therefore redefined as plasma clearance rate (PCR). For the calculation ofC3 synthesis rates during different periods ofthe inflammatory process, we used the plasma C3 concentrations, PCRs, and distribution factors calculated for the period of inflammation.
Statistics. The C3 clearance curves were analyzed by initial curve fitting according of the method of Foss (18) followed by least squares estimation of the nonlinear parameters (19) .
Results
Studies in normal rabbits. Since C3 metabolism in the rabbit has not been studied with purified rabbit C3, initial studies were performed to establish the constants for C3 turnover during the steady state in normal animals. The mean plasma C3 concentration in our animals (n = 8) was 1.23±0.3 mg/ml (SD) and the mean plasma volume was 31.5±3.5 ml/kg (SD), as determined by the 59Fe-RBC and the '25I-C3 dilution methods. Fig.  2 shows the means and standard deviations of total body radioactivity, PCR, and urinary excretion of '25I-C3 for eight NZW rabbits before subtraction of the rapidly removed fraction. The '25I-C3 clearance curves and two corresponding linear plots after normalization to fit the two-compartment model based on data obtained from eight normal rabbits are depicted in Fig. 3 . Table  I lists Table III ). bl, the slope of the clearance Total body radioactivity, urinary excretion, and plasma clearance curves of 1251-C3 in eight normal NZW rabbits plotted as a fraction of the total injected radioactivity before removal of the rapidly cleared fraction (mean±SD). The total body radioactivity was calculated by subtraction of the cumulative urinary activity from the total injected amount.
The FCRs were calculated by the curve analysis method as well as by the ratio between urinary excretion and mean plasma activity. Both methods gave similar results during normal steady state conditions (Table II, Fig. 3 ). The synthesis rate of 2.7±0.3% of the plasma pool per hour (1.05 mg/kg per h) maintained constant levels for a daily turnover of almost 50% of the total body C3 pool of the rabbit (51.5 mg/kg per d). The Fig. 4 shows that during the initial 24 h after the induction of inflammation,~-20% of the circulating '25I-C3 pool was cleared from the intravascular space. The rate of disappearance was approximately twice as fast as the half-life during steadystate, and radioactivity lost from the circulation could not be recovered in urine. To examine the site of redistribution of the plasma C3, one rabbit was killed 24 h after the simultaneous induction of pleurisy and injection of two radiolabeled compounds, '251-C3 and '3'I-RSA. Of the '25I-C3 activity, 19.2% was found in the pleural cavity with 20.3% of the '3'I-RSA, suggesting that the redistribution of C3 into the inflammatory site was entirely responsible for the loss of activity from the circulation. In addition, the initial redistribution was not unique to C3, for albumin entered the pleural space as easily as C3.
To define more precisely the effect of inflammation, two rabbits were used as their own controls for measuring C3 metabolism in the normal state with '25I-C3 and metabolism during inflammation after injection of '3'I-C3. The curve analyses and U/X ratios of both preparations were then compared with each other after correction for the different isotope decay rates (Table  III) . The results again suggested that radiolabeled C3 was redistributed from the circulation into the extravascular space.
In particular, C,, C2, and jl/j2, three parameters of the curve analyses, describe the distribution of C3 in the two compartments. Cl, an indicator of the intravascular space, declined, whereas C2 increased, representing an extravascular gain. The ratio between the two compartments (jl/j2) also changed in favor of the extravascular space. Table III ratio in the turpentine-injected animals fall within 1 SD of the eight normal rabbits (Table I) , the changes in the PCR were greater than 1 SD. The typical response to turpentine pleurisy in NZW rabbits is a 2.3-fold rise of the total plasma C3 concentration, as has previously been shown by our laboratory. (Giclas, P. C., U. Manthei, B. Thron-Weber, and R. C. Strunk. Manuscript submitted for publication.) To determine whether this increase in C3 concentration was due to neosynthesis or redistribution of preformed protein, synthesis was blocked in vivo by cycloheximide injection in dosages that are known to inhibit protein synthesis in rabbits (16) . Fig. 5 shows the response of rabbits to 15 mg/kg of cycloheximide, with and without the induction ofturpentine pleurisy. Inflammation only was induced in group 1, and the typical elevation ofthe plasma C3 concentration was seen at 24 h. When the inhibitor was injected at the same time as turpentine, a decline of the plasma C3 concentration was noted after a lag period of 6 h (group 3). The same pattern was UIX is the ratio between the urinary excretion of 125I and the mean plasma activity during the same time period. Synthesis rates were calculated according to Eq. 6 using a mean plasma volume of 31.5±3.5 mg/kg (whole blood volume = 51.5±3 ml, hematocrit = 37.5±2.5%) and a C3 concentration of 1.23±0.3 mg/ml. observed in animals that received cycloheximide only (group 4). When the drug was injected 12 h after the induction of pleurisy (group 2), an increase in the C3 level was observed between 12 and 18 h, similar to that seen in the rabbits ofgroup 1. However, after 18 h (6 h after cycloheximide) a fall in the plasma C3 level occurred parallel to that observed in groups 3 and 4. Linear regression of the coordinates of groups 3 and 4 at 6, 12, and 24 h with the methods described for 125I-C3 showed that the plasma C3 concentrations declined with a half-life of 39 h after total blockade ofprotein synthesis, similar to the halflife calculated after injection of '25I-C3, i.e., 40±6 h. After it was established that changes in plasma C3 concentration were due in part to increased neosynthesis, an attempt was made to calculate synthesis rates for individual time periods C, and C2 are the yintercepts of the linear plots in the two-compartment curve analysis method. The PCR is the sum of the catabolism and the shift into the pleural space (see Fig. 2 ), and represents the fraction of the total body radioactivity in the intravascular (C,) and extravascular (C2) compartments. The U/X is the fraction of circulating radioactivity excreted in 24 h and represents the FCR. The ratio between the intra-and extravascular spaces is expressed by jl/j2.
throughout the course of the inflammation. Unlike the results of an injection of ACTH as a stimulus of fibrinogen synthesis (4), in our model ofturpentine pleurisy an accelerated clearance rate of '251-C3 from the circulation accompanied by a simultaneous shift into the extravascular compartment was observed.
Since the synthesis rate has to compensate for accelerated clearance from the circulation, we replaced the FCR with the PCR (Eq. 7) and used 1.53 (Table III) as factor for the total body distribution instead of 1.44 (rabbits 7 and 8). This permitted characterization of the distribution between the two compartments in the same rabbits during steady state (Table III) . Fig.  6 shows that with these assumptions a synthesis rate equal to 480% ofbaseline was calculated for the first 24 h after turpentine injection. This was reflected in a 60% increase in the plasma C3 concentration between 12 and 24 h. After this initial spike, the synthesis rate continuously decreased throughout the course of inflammation. The corresponding plasma C3 concentrations are also shown in Fig. 6 . C3 activation. After the activation ofC3, some C3 fragments formed can enhance the inflammatory response. To determine whether activation occurred in the pleural exudate, a process which could explain the slightly larger G/Xratio after turpentine injection, we submitted a sample of 6-h pleural fluid to crossed immunoelectrophoresis against goat anti-rabbit C3. Fig. 7 shows the result where the arc a represents the native fraction and b the cleaved molecule, indicating that activation had occurred during this early stage of the pleurisy. Similar techniques showed no fragments in the 6-h plasma sample.
Discussion
The induction ofturpentine pleurisy, a local inflammatory process in the rabbit, was followed by a 2.3-fold increase in the plasma C3 concentration. This was the result of measurable alterations in all three parameters of protein metabolism: synthesis, distribution, and catabolism. Distribution was the first parameter to be altered. After turpentine was injected into the right pleural cavity, a shift of -20O% of the circulating C3 into that pleural space occurred within the first 24 h after injection. Since '3'I-RSA appeared in the pleural space in the same proportions as the '25I-C3, it seems likely that nonspecific local permeability changes rather than specific transport mechanisms were involved. Spector and Willoughby (20) showed that similar permeability changes occurred in the first 6 h after turpentine injection into the pleural space of the rat. Based on the observation that the accumulation of pleural fluid was inhibited by pretreating the animals with a combination of mepyramine maleate and sodium salicylate, they concluded that the turpentine did not act directly on the vessel walls of the pleural cavity. We assume that in our experiments similar mechanisms resulted in the nonspecific influx ofC3 and other proteins into the rabbits' pleural cavities, forming the inflammatory exudate and accounting for the observed loss of iodinated C3 from the circulation. The phase of increased permeability and influx of circulating proteins in the pleural cavity seems to be limited to the first 24 h after the injection of turpentine. Fig. 4 shows that after this time period the slope of the '251-plasma C3 clearance curve returned parallel to the pre-injection slope. Evidence for a shift of circulating C3 into the pleural cavity was also found by analyzing the two plasma clearance curves during steady state and inflammation (Table III) . During inflammation, the intravascular space (C,) decreased, whereas the extravascular space (C2) was enlarged and the rate of extravascular accumulation (1j/j2) increased. These changes were not statistically significant.
C3 Conversion in Pleural Fluid
Two methods were used to determine the FCR during inflammation. The plasma '251I-C3 clearance curve was analyzed to determine the sum ofthe catabolic rate and the undirectional flux into the pleural cavity. The ratio between the urinary excretion and the mean plasma activity was an expression of the true FCR. The comparative curve analysis of steady state conditions and inflammation in the same animal (Table III) showed that by this method there was a change in the PCR of almost 30%. The obvious fact that our model does not involve a steady state of inflammation limits the validity of the results to a gross comparison between normal conditions and inflammation. For the curve analysis method this is due to the fact that the entire plasma clearance curve is needed for calculation of the parameters. Consistent U/X ratios can be obtained only after a total body equilibration of the radiolabeled compound in reached, and this occurs only after 48 h for 1251-C3. The higher PCR shows that '25I-C3 is removed from the circulation but does not appear in the urine at the same increased rate, suggesting a probable accumulation in the extravascular space. Activation of C3 at the inflammatory site may account for the slightly increased U/X. The observed fragmentation of C3 in the 6-h pleural fluid sample as shown in Fig. 7 is evidence that such activation occurred. Possible mechanisms for C3 conversion in the pleural fluid include action by enzymes released from lysed cells, activation of complement by altered membranes or subcellular constituents, and enzymes generated by activation of coagulation and fibrinolytic pathways. The third parameter of protein metabolism, synthesis, was determined indirectly. During steady state the synthesis rate is equal to the FCR. During turpentine pleurisy, however, a 2.3-fold increase of the plasma C3 level after a 12-h lag period was observed (Fig. 6) . Possible reasons for the rise in the plasma C3 concentration are increased synthesis, decreased catabolism, and redistribution from the extravascular to the intravascular compartment. As we have shown above, the FCR was accelerated rather than decreased. Redistribution and decreased catabolism were also ruled out by the cycloheximide experiments summarized in Fig. 5 , which showed that inhibition of protein synthesis blocked the increase in C3 concentration. This left increased protein neosynthesis as the reason for the observed rise in the plasma C3 concentration.
As Atencio and Reeve (4, 14) have shown, it is possible to calculate synthesis rates during conditions in which the plasma concentrations change and the exchange ratios remain constant. For the calculation of the increase in the C3 synthesis rate during turpentine pleurisy, we used the PCR and the altered ratios between the intra-and extravascular compartments (Table  III) . In doing so, our results may have been too low for the early phases of inflammation and too high for the later phases, but we feel that they adequately illustrate the pattern. A fivefold increase of the C3 synthesis rate was observed following a 12-h lag period after turpentine injection (Fig. 6) . A change of this magnitude caused the plasma C3 concentration to rise to 160% of baseline within 12 h and to 230% of baseline over the next 48 h. It is possible that the initial 12-h lag period was needed for the development oflocal inflammation and the transmission of a signal to increase the C3 synthesis from the site of inflammation to the production site of the acute phase proteins, most likely the liver.
The interpretation of changes in metabolism during inflammation depends on the validity of using purified C3 protein covalently linked to 1251I to determine rates of synthesis, catabolism, and distribution of this protein. The methods here described were initially worked out by Mathews (13) and have been extensively applied and modified for studies of the metabolism of albumin and fibrinogen in the rabbit by Reeve and coworkers (4, (14) (15) (16) 21 partial activation ofC3 was likely. It was impossible to determine the percentage of the inactivated fraction since the detection of cleaved C3 in the purified preparation was limited by two problems. First, the hemolytic assay for rabbit C3 is much less sensitive than the assay for the human component (6) . Second, when the specific hemolytic activities of the purified and the starting material were compared, in all cases activity of the purified preparation was higher because ofthe presence ofnatural inhibitors of C3 in normal rabbit plasma (6) . Further opportunities to damage the C3 molecule are present in the procedure of radioiodination. The method chosen in these studies is believed to be less damaging than the chloramine-T method (9) since effective binding of the iodine to the protein is achieved with a lower chloramide-to-protein ratio than when chloramine-T is used. The combination of the purification procedure with the method of radioiodination made it likely that the preparations injected into the rabbits contained a small but significant fraction of radiolabeled C3 fragments. This conjecture is supported by the work of Alper and Ruddy. Alper and coworkers (23) found that 13'I-C3 fragments were cleared from the circulation of volunteers at a very rapid rate, distinctly different from the clearance rates observed for the native material. Ruddy et al. (10), who reviewed 144 studies of C3 metabolism in humans, pointed out that the rapidly cleared fraction of the radioactivity reported by some investigators represented iodinated C3 fragments that were metabolized immediately after injection.
They were able to link the size of this pseudocompartment to the loss of specific hemolytic activity before the injection. The plasma clearance curves of our experiments were corrected by the removal of the rapidly cleared fraction as recommended by Ruddy et al. (10). The method of biological screening, as described by Charlesworth and Williams (17) failed to show an advantage over direct injection of the '25I-C3. It is possible that the persistence of a rapidly cleared fraction after the biological screening was due to cleavage of C3 during reactions related to the exchange transfusion, such as hypovolemic shock in the donor, transfusion reactions in the recipients, and the introduction of tissue factors during the injection.
With the above-mentioned limitation ofour results in mind, we compared the normal metabolic parameters of homologous C3 in the rabbit with those in humans (10, 23, 28) and those of human C3 in rabbits (17) ( Table IV) . The rates of C3 metabolism in the rabbit are comparable to those in man. The similarity between our data and those of Charlesworth et al. (17) suggests that heterologous and homologous C3 are processed alike by the rabbit during normal steady-state conditions. When compared with IgG and albumin, C3 has a relatively high rate of metabolism (Table V) . This may be partially explained by the fact that C3 is the substrate for not only the specific C3 convertases of the classical and alternative pathway, but also for a number of proteases not specific for the complement pathway.
It is rare to find studies that compare all three parameters of protein metabolism (synthesis, distribution, and catabolism) during local inflammation with the normal steady state. Chelladurai et al. (3) induced turpentine myositis in rabbits and found that the normally very high FCR for CRP was not influenced by this inflammatory process. Atencio (24) injected typhoid vaccine into NZW rabbits and observed that plasma fibrinogen increased to 216% of baseline within 20 h. '25I-fibrinogen was rapidly cleared from the circulation but did not appear in the urine at the same rate, suggesting an accumulation of fibrinogen or its split products in the interstitial fluids due to temporarily increased vascular permeability. Lerner et al. (25) showed clearance of 18.5-19.5% ofcirculating '3'I-fibrinogen after the intravenous injection of bacterial lipopolysaccharide. Takahashi et al. (11) measured the incorporation of '4C-amino acids into C9 after the intramuscular injection of turpentine into mice and found a fivefold increase in the synthesis rate, but this method does not allow any assessment ofthe distribution and catabolism. Reeve and Franks (26) have divided the acute phase response of fibrinogen into four stages. The first stage is a brief quiescent period varying in time with the stimulus chosen. In the second stage, a steep rise in plasma fibrinogen levels is characterized by a rapid burst of fibrinogen synthesis, often as high as 10-20-fold. Significant changes in the catabolic rate often are not seen but may follow the stimulation of efflux pathways, as seen after bacterial lipopolysaccharide injection (24, 25) . The search for stimulators of fibrinogen synthesis revealed the role ofACTH as discussed by Atencio et al. (4) . Durift the third stage of the fibrinogen acute phase response, plasma fibrinogen fluctuates about a raised level. In this and the previous phase the plasma concentration depends on the interaction between mechanisms altering fibrinogen efflux from the intravascular space, and those stimulating synthesis. The fourth stage is the slow return to prestimulation conditions, characterized by a decrease of the synthesis rate as well as the return of the efflux constants to normal. Our data suggest that during turpentine pleurisy the normal metabolic parameters ofC3 in the rabbit upidergo changes similar to those described above. A shift of circulating C3 into the site of inflammation occurred, as did a small increase in the catabolism. This was offset early by a fivefold acceleration in the synthesis rate, resulting in a 2.3-fold increase of the plasma C3 level. The methodology used in the studies here reported allows only a rough estimate of the changes in the synthesis rate. The changes found were similar to those reported for another component ofcomplement, C9, in a different species with unrelated methods (5) . The fact that a systemic acute phase response of C3 synthesis followed local induction of inflammation suggests that a locally produced signal reaches the site of C3 production, inducing the observed increase in synthesis. For fibrinogen, Chen (26) showed that denervating the rabbit ear did not inhibit the acute phase response to ear burn, whereas arresting the circulation did. More recently Sipe et al. (27) showed that interleukin I may fulfill the requirements for the circulating signal to induce increased synthesis of serum amyloid A, an APP in the mouse. The regulation of C3 metabolism is important in maintaining the balance of host defense mechanisms, and we are currently pursuing further studies to identify and characterize the messenger(s) that participate in this process.
